EX-23.1 4 ex231-deloittexformsx3cons.htm EX-23.1 Document
Exhibit 23.1
]
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 18, 2021 relating to the financial statements of Foghorn Therapeutics, Inc. appearing in the Annual Report on Form 10-K of Foghorn Therapeutics, Inc. for the year ended December 31, 2020. We also consent to the reference to us under the heading "Experts" in such Registration Statement.

/s/ Deloitte & Touche LLP

Boston, Massachusetts
February 14, 2022